Professor of Anesthesia; Assoc. Director of the MGD Centre for Medicinal Cannabis Research; Canada Research Chair in Prevention & Management of Chronic Pain
Joined September 2015
- Tweets574
- Following343
- Followers726
- Likes1.1K
Our study of 24,987 Canadian Veterans receiving cannabis for medical purposes found PTSD and chronic pain were leading diagnoses; 43% were authorized for >3 g/day; 48% of claims were for dried flower.
Time to align clinical practice, evidence & policy? utppublishing.com/doi/10.313…
Our @BMJMedicine network meta-analysis (151 trials) found no moderate or high-certainty evidence that any drug provides important benefits for fibromyalgia.
Some drugs may help some patients - evidence is low certainty and benefits are typically small:bmjmedicine.bmj.com/content/…
Our survey of 770 Canadians living with chronic pain found that half were not attending any healthcare provider for care, and only 1 in 4 were satisfied with management of their chronic pain: tandfonline.com/doi/full/10.…
Healthcare is finite. If more high value care is to be provided, low value care must be reduced #GIN2026
COI, dissemination and sustainability remain challenges for CPGs in the Philippines #GIN2026
Important work led by @dkchu finds untrustworthy trials are prevalent in allergy research: pubmed.ncbi.nlm.nih.gov/4264…
Our pilot trial found that a definitive RCT of cannabis to prevent persistent pain after total knee replacement is likely feasible if we expand clinical sites for recruitment and switch from oil drops to capsules: link.springer.com/article/10…
I’m delighted to take on a new role as Director of the IPRC, and the task of filling the big shoes of Norm Buckley.
healthsci.mcmaster.ca/jason-…
Our recent commentary summarizes evidence that supports the role of pharmacists in helping interested patients to taper opioids before joint replacement surgery: aoj.amegroups.org/article/vi…
While fair criticism is welcome and may provide important opportunities to improve or correct publications, erroneous claims offer an opportunity for correction. Our team recently had such opportunity: painphysicianjournal.com/cur…
We found moderate to high certainty evidence that beta-blockers and CGRP-targeted therapies probably reduce migraine frequency. Calcium channel blockers and anticonvulsants may also be effective for reducing migraine frequency but are less well tolerated: ebm.bmj.com/content/early/20…
Our review found low certainty evidence that several interventional procedures for chronic spine pain show risk of deep infection, dural puncture, temporary altered level of consciousness and prolonged pain or stiffness: bmjopen.bmj.com/content/16/6…
Our review found high certainty evidence that 5 in every 100 active-duty Canadian Armed Forces members live with PTSD and moderate certainty evidence that 12 in every 100 Canadian veterans probably live with PTSD:
militaryhealth.bmj.com/conte…
New review out on migraine prophylaxis. Monoclonal antibodies are promising, but trials require replication. Evidence for botulinum toxin, propranolol, topiramate, and valproate was largely at high risk of bias:
acpjournals.org/doi/10.7326/…
